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Abstract. 
 
Carcinoma cells selected for their ability to 
migrate in vitro showed enhanced invasive properties 
in vivo. Associated with this induction of migration was 
the anchorage-dependent phosphorylation of p130CAS 
(Crk-associated substrate), leading to its coupling to 
the adaptor protein c-CrkII (Crk). In fact, expression of 
CAS or its adaptor protein partner Crk was sufficient 
to promote cell migration, and this depended on CAS 
tyrosine phosphorylation facilitating an SH2-mediated 
complex with Crk. Cytokine-stimulated cell migration 
was blocked by CAS lacking the Crk binding site or 
Crk containing a mutant SH2 domain. This migration 
response was characterized by CAS/Crk localization to 
membrane ruffles and blocked by the dominant-nega-
tive GTPase, Rac, but not Ras. Thus, CAS/Crk assem-
bly serves as a “molecular switch” for the induction of 
cell migration and appears to contribute to the invasive 
property of tumors.
 
D
 
uring
 
 wound repair and inflammation, cells can be
induced to migrate by cytokines or adhesive pro-
teins within the provisional extracellular matrix
(ECM)
 
1
 
 (Clark et al., 1996). Recent evidence indicates
that cytokine receptors as well as integrins transmit signals
in response to extracellular cues (for reviews see Schwartz
et al., 1995; Parsons, 1996). While these biochemical sig-
nals are likely to be involved in the induction of cell migra-
tion, little is known about the actual signal transduction
events responsible for this process or how they impact the
cells’ migration machinery. 
Ultimately, the biochemical signals responsible for con-
trolling cell migration must impact adhesion and deadhe-
sion of integrin receptors as well as organization of the ac-
tin and myosin cytoskeleton since these events are critical
for movement (Huttenlocher et al., 1996). However, the
complexity of cell motility suggests that multiple signaling
mechanisms exist to regulate this process. For example,
Ras/MAP kinase (ERK1 and 2) signaling has been shown
to promote phosphorylation of myosin light chain kinase
leading to activation of the actin/myosin motor and cell
migration (Klemke et al., 1997), whereas the Rho family of
small GTPases (i.e., Rac, Rho, Cdc42) control actin orga-
nization associated with cell motility (Ridley et al., 1992;
Takaishi et al., 1993; Hotchin and Hall, 1995; Michiels et
al., 1995). Furthermore, the adhesion-dependent signaling
molecules focal adhesion kinase (FAK) and c-src may be
involved in focal contact disassembly during cell migration
(Ilic et al., 1995; Rodier et al., 1995; Cary et al., 1996;
Gilmore and Romer, 1996; Parsons, 1996; Hanks and
Polte, 1997). Phosphatidylinositol 3-kinase (Rodriguez-
 
Viciana et al., 1997) and PLC
 
g
 
 
 
(Chen et al., 1994) are also
thought to regulate cell migration. Therefore, it is likely
that cell migration depends on the coordinate regulation
of a number of these signaling events.
Ligation of integrin or cytokine receptors promote a
cascade of biochemical signals, including the activation of
tyrosine kinases leading to phosphorylation of multiple
cellular substrates. A family of adaptor proteins (Nck,
Crk, Grb2), which consist primarily of src homology 2
(SH2) and 3 (SH3) domains, coordinate these biochemical
events by assembling signal-generating complexes. For ex-
ample, the SH2 domains of these adaptor proteins bind
specifically to phosphotyrosine-binding sites in many sig-
naling molecules, while the SH3 domains are critical for
coupling to effector molecules and targeting of signaling
complexes to discrete sites within the cell (Bar-Sagi et al.,
1993). 
 The adaptor protein p130CAS (Crk-associated sub-
strate) is a member of a family of structurally related pro-
teins (i.e., Efs/Sin and Hef 1) that was originally identified
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as a prominent tyrosine-phosphorylated protein in v-crk–
and v-src–transformed cells (Sakai et al., 1994; Greulich
and Hanafusa, 1996; Matsuda and Kurata, 1996). CAS
contains an SH3 domain, two proline-rich regions, and a
substrate domain consisting of 15 potential SH2-binding
motifs (Sakai et al., 1994). C-Crk II (Crk) is an adaptor
protein that contains an SH2 and two SH3 domains capa-
ble of interacting with numerous effector molecules, in-
cluding tyrosine-phosphorylated CAS (for reviews see
Feller et al., 1994
 
a
 
; Matsuda and Kurata, 1996). In fact, 9
of the 15 tyrosine phosphorylation sites present in the sub-
strate domain of CAS conform to the SH2-binding motif
for Crk (YD(V/T)P, suggesting that Crk is the primary
“docking protein” for CAS. However, Nck also binds to
CAS and may play a role in regulation of CAS activity
(Schlaepfer et al., 1997). Recently, it was reported that cell
adhesion to ECM proteins promotes FAK and c-src kinase
activity leading to tyrosine phosphorylation of CAS and its
association with Crk or Nck (Vuori et al., 1996; Schlaepfer
et al., 1997). While this suggests a role for these molecules
in mediating cellular responses to the ECM, the biological
consequences of this signaling event are not known. 
In this report, we investigate the role of CAS and Crk in
regulation of cell migration on the ECM. Evidence is pro-
vided that tyrosine phosphorylation of CAS is associated
with induction of migration and enhanced invasive poten-
tial of carcinoma cells in vivo. This migration response was
shown to depend on the assembly of a CAS/Crk adaptor
protein complex, and the resulting migration was dis-
rupted by a dominant-negative form of Rac, but not Ras.
These findings suggest that formation of a CAS/Crk adap-
tor protein complex serves as a “molecular switch” facili-
tating a Rac-dependent cell migration response on the ex-
tracellular matrix. 
 
Materials and Methods
 
Cells and Cell Culture
 
Previous reports have described the FG human pancreatic carcinoma cell
adhesive and migratory properties and integrin profile (Klemke et al., 1994).
FG-M is a cell line derived from FG cells that are migration competent on
vitronectin. To obtain these cells, FG cells were serum starved for 48 h be-
fore being removed from the culture dish with Hanks’ balanced salt solu-
tion containing 5 mM EDTA and 25 mM Hepes, pH 7.2, and allowed to
migrate for 24 h on vitronectin-coated (10 
 
m
 
g/ml in PBS, pH 7.4) migra-
tion wells as previously reported (Klemke et al., 1994). The migratory
cells on the underside of the membrane were removed with trypsin/
EDTA solution (GIBCO BRL, Gaithersburg, MD) and cultured in RPMI
10% FCS until enough cells were obtained to repeat the process. After 10
rounds of selection, we obtained a stable cell line (FG-M cells) that spon-
taneously migrates on vitronectin to levels comparable to that of parental
FG cells on collagen. FG and FG-M cells were grown in RPMI 1640
(GIBCO BRL) supplemented with 10% FBS and 50 
 
m
 
g/ml gentamicin
and were free from mycoplasma during these studies. COS-7 cells were
grown in DME with 10% FBS and 50 
 
m
 
g/ml gentamicin. Before testing, all
cells were starved for 24–48 h by replacing serum-containing culture me-
dia with FBS-free media. 
 
Expression Vectors and Constructs
 
The expression plasmid pUCCAGGS containing full-length CrkII as well
as c-CrkII cDNA in which either the amino-terminal SH3 domain (tryp-
tophan 109 to cysteine) or the SH2 domain (arginine 38 to valine) were
mutated have been described previously (Matsuda et al., 1993, 1994;
Tanaka et al., 1993). The pEBG expression plasmid containing glu-
tathione-S-transferase (gst)-tagged or untagged wild-type p130CAS or
CAS with an in frame deletion of its substrate domain (CAS-SD, amino
acids [aa] 213–514) has been described previously (Mayer et al., 1995).
Myc-tagged dominant-positive Rac1 (Q61L) or dominant-negative Rac 1
(N17) in pcDNA3, and dominant-negative Ras (N17) in pCMV5 vectors
have been described previously (Minden et al., 1995). 
 
Antibodies and Reagents
 
Anti-Crk was from Transduction Laboratories (Lexington, KY). Anti-
CAS used for Western blotting and immunofluorescent staining was from
Transduction Laboratories, and anti-CAS antibodies for immunoprecipi-
tation experiments were from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). Anti-myc antibody 9E10 and anti-Ras (259) was from Santa Cruz
Biotechnology. Anti-gst and antiphosphotyrosine monoclonal antibody
(4G10) was from Upstate Biotechnology, Inc. (Lake Placid, NY). Goat
anti–rabbit and anti–mouse antibodies were from Bio-Rad Labs (Her-
cules, CA). Anti-FAK antibody BC3 was kindly provided by Dr. J. Thomas
Parsons (University of Virginia Medical Center, Charlottesville, VA). Hu-
man recombinant EGF, IGF-1, and insulin were obtained from Genzyme
(Cambridge, MA). 
 
Adhesive Ligands
 
Vitronectin was prepared as described by Yatohgo et al. (1988). Fibronec-
tin and collagen type I were obtained from Upstate Biotechnology, Inc.
 
Transfection of COS-7 and FG -M Cells
 
Transient transfection of COS cells was performed as previously de-
scribed (Klemke et al., 1997). Briefly, to investigate the role of CAS or
Crk in cell migration, COS-7 cells (0.75 
 
3 
 
10
 
6
 
 cells/10-cm plate) were
cotransfected with lipofectamine (20 
 
m
 
l/10-cm plate; GIBCO BRL) and
1.5 
 
m
 
g of the expression vector containing the cDNA encoding wild-type
and/or mutant forms of c-Crk or CAS, along with 0.5 
 
m
 
g of a reporter con-
struct encoding 
 
b
 
-galactosidase (pSV–
 
b
 
-galactosidase; Promega Corp.,
Madison, WI). In some cases, cells were transfected with the expression
vectors encoding wild-type CAS and Crk (1.5 
 
m
 
g of each construct per
plate) along with dominant-negative Rac construct (1 
 
m
 
g/plate) or Ras
(0.25 
 
m
 
g/plate) as described above. Mock cells were transfected as de-
scribed above with the appropriate amount of the empty expression vec-
tors. Cells were allowed to incorporate the cDNA constructs for 6–8 h,
washed, and then allowed to incubate for 40 h, which provides optimal
transient expression. FG-M cells (1 
 
3
 
10
 
6
 
 cells/10-cm dish) were cotrans-
fected with lipofectamine (40 
 
m
 
l/10-cm plate) and 10 
 
m
 
g of the expression
vector containing CAS without its substrate domain (CAS-SD) or the
empty expression vector along with the 
 
b
 
-galalctosidase reporter con-
struct (10 
 
m
 
g/10-cm plate). Cells were allowed to incorporate the cDNAs
for 16 h, washed, and then incubated for 36 h. COS and FG-M cells were
then prepared for cell migration or analyzed for expression of specific pro-
teins as described below. Cells cotransfected with 
 
b
 
-galactosidase were
developed using X-gal as a substrate according to the manufacturer’s rec-
ommendation (Promega Corp.). In typical transfection experiments of
FG-M cells, we achieved 10–15% expression efficiency, and in COS-7 cells
we obtained 40–60% efficiency providing a 10–30-fold increase in the
level of Crk, 10–15-fold increase in CAS, or 10–30-fold increase in Rac
and Ras compared with endogenous levels of these proteins as deter-
mined by Western blotting.
 
Haptotaxis Migration Assays
 
Cell adhesion and migration assays were performed as previously de-
scribed with minor modifications (Klemke et al., 1997). Briefly, cell migra-
tion assays were performed using modified Boyden chambers (tissue cul-
ture–treated, 6.5-mm diameter, 10-
 
m
 
m thickness, 8-
 
m
 
m pores, Transwell
 
®
 
;
Costar Corp., Cambridge, MA) containing polycarbonate membranes
coated on the underside of the membrane with 10 
 
m
 
g/ml vitronectin, fi-
bronectin, or collagen type I in PBS for 2 h at 37
 
8
 
C, rinsed once with PBS,
and then placed into the lower chamber containing 500 
 
m
 
l migration
buffer (fibroblast basal medium [FBM] with 0.5% BSA; Clonetics, San
Diego, CA). Serum-starved cells were removed from culture dishes with
Hanks’ balanced salt solution containing 5 mM EDTA and 25 mM Hepes,
pH 7.2, and 0.01% trypsin, washed twice with migration buffer, and then
resuspended in FBM 0.5% BSA (10
 
6
 
 cells/ml). 50,000–100,000 cells were
then added to the top of each migration chamber and allowed to migrate
to the underside of the top chamber for various times in the presence or 
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absence of either insulin (25 
 
m
 
g/ml), insulin-like growth factor 1 (IGF-1;
20 ng/ml), or epidermal growth factor (50 ng/ml), which had been added
to the lower chamber. The nonmigratory cells on the upper membrane
surface were removed with a cotton swab, and the migratory cells attached
to the bottom surface of the membrane stained with X-gal substrate as de-
scribed above (for
 
 
 
b
 
-galactosidase–expressing cells) or 0.1% crystal violet
in 0.1 M borate, pH 9.0, and 2% ethanol for 20 min at room temperature.
The number of migratory cells per membrane were either counted with an
inverted microscope using a 40
 
3
 
 objective, or the stain was eluted with
10% acetic acid, the absorbance was determined at 600 nm, and migration
was enumerated from a standard curve. Each determination represents
the average of three individual wells, and error bars represent the stan-
dard deviation (SD). All values have had background subtracted, which
represents cell migration on membranes coated on the bottom with BSA
(1%). In control experiments, cell migration on BSA was less than 0.01%
of the total cell population.
 
Chick Embryo Metastasis Assay
 
The chick embryo metastasis assay was performed as previously described
(Brooks et al., 1997). Briefly, FG or FG-M carcinoma cells (5–10 
 
3 
 
10
 
6
 
)
were inoculated on the back of the chorioallantoic membrane of a 9-d-old
chick embryo and allowed to incubate for 7–9 d. Embryos were then
killed, tumors were excised, and the weights were determined. Pulmonary
metastasis was quantified by determining the percentage of human cells
present in a single cell suspension of whole lung tissue by flow cytometry
as described by Brooks et al. (1997). 
 
Cell Adhesion and Transfection Efficiency
 
Cell adhesion was performed according to Klemke et al. (1994) with mi-
nor modifications. Briefly, 48-well cluster plates (polystyrene, non-tissue
culture–treated; Costar, Cambridge, MA) were coated with either 10 
 
m
 
g/ml
vitronectin, fibronectin, or collagen 1 in PBS, pH 7.4. Proteins were al-
lowed to bind for 2 h at 37
 
8
 
C before the wells were rinsed and blocked for
1 h with 1% heat-denatured BSA (RIA grade; Sigma Chemical Co., St.
Louis, MO) in PBS. Cells were treated and harvested as for the migration
assay and added to the wells at a concentration of 100,000 cells/0.1 ml
FBM-BSA. Nonadherent cells were removed by washing, and the adher-
ent cells were stained with crystal violet and enumerated from dye uptake
or stained with X-gal substrate and counted as described above. Each data
point was calculated from triplicate wells and was expressed as the mean
 
6 
 
SD. Nonspecific cell adhesion as measured on BSA-coated wells has
been subtracted.
 
Immunoprecipitation and Immunoblotting of Proteins
 
Immunoprecipitation and immunoblotting of proteins was performed as
previously described (Klemke et al., 1997). Briefly, cells were rinsed twice
with PBS and then lysed with either RIPA buffer for Western blotting of
total cellular proteins or NP-40 buffer (50 mM Tris, pH 7.5, containing 150
mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate, a cocktail of pro-
tease inhibitors [Boehringer Mannheim cocktail tablet; Boehringer Mann-
heim Corp., Indianapolis, IN], and 1% NP-40) for immunoprecipitation of
cellular proteins for 1 h at 4
 
8
 
C. The protein concentration of the samples
were normalized before either direct immunoblotting of total cell proteins
or immunoprecipitation of equivalent amounts of proteins with Crk, CAS,
or gst antibodies bound to protein A– or G–Sepharose beads. Samples
were analyzed by immunoblot analysis using antibodies to Crk, CAS, gst,
or antiphosphotyrosine monoclonal antibody (4G10) and horseradish per-
oxidase–conjugated goat anti–mouse or rabbit secondary antibodies and
the ECL system. In some cases, the immunoblots were stripped and re-
probed with antibodies according to the manufacturer’s recommendations
(ECL; Amersham Corp., Arlington Heights, IL).
 
Immunofluorescent Staining and Confocal Microscopy
 
COS-7 cells either transfected with CAS and Crk or mock-transfected
cells were removed from the culture dish and resuspended in FBM (0.5%
BSA) as described above and allowed to attach to glass coverslips coated
with 10 
 
m
 
g/ml vitronectin for 2 h at 37 
 
8
 
C. In some cases, cells grown on
glass coverslips were serum-starved for 24 h and then treated with or with-
out insulin (25 
 
m
 
g/ml) or IGF-1 (20 ng/ml) for 15 min. Cells were fixed in
4% paraformaldehyde, permeablized with 0.2% Triton X-100, and stained
with rhodamine-conjugated phalloidin and anti-Crk or anti-CAS antibod-
ies followed by FITC-conjugated goat anti–mouse or rabbit secondary an-
tibodies. Cell fluorescence was analyzed with a laser confocal microscope
(model 1024; Bio-Rad Labs) and a Zeiss Axiovert microscope (Thorn-
wood, NY) focused at the cell–substratum interface. 
 
Results
 
Selection of FG Pancreatic Carcinoma Cells with 
Increased Migration In Vitro and Metastatic Properties 
In Vivo 
 
While cell adhesion to the extracellular matrix is required
for cell migration, it is not sufficient. For example, FG
pancreatic carcinoma cells attach to vitronectin but fail to
migrate on this adhesive ligand, whereas, they readily mi-
grate on collagen (Klemke et al., 1994). This may be ex-
plained by differences in adhesion-dependent signaling
events that ultimately facilitate cell movement. To identify
putative signaling molecules that are associated with the
migratory phenotype, FG cells were allowed to attach to
either collagen or vitronectin and examined for differ-
ences in their phosphoprotein profile. As shown in Fig. 1,
cell attachment to collagen, a migration-competent ligand,
resulted in significantly enhanced tyrosine phosphoryla-
tion of a 70- and 125–130-kD protein(s), whereas, cell ad-
hesion to vitronectin, which does not support FG cell mi-
gration, showed only little tyrosine phosphorylation of
these proteins. 
To determine whether the phosphorylation status of the
125–130-kD phosphoprotein(s) was associated with the
migratory phenotype of these cells, we first selected a sta-
ble population of FG cells that were migration competent
on vitronectin since a small percentage of the parental FG
cells (
 
,
 
0.05%) were capable of movement on this sub-
strate. After 10 rounds of selection, a stable population was
Figure 1. FG cell migration on collagen is associated with in-
creased tyrosine phosphorylation of p125–130 proteins. Serum-
starved FG cells were held in suspension (0 time point) or al-
lowed to attach to Petri dishes coated with collagen (COLL) or
vitronectin (VN) for various times before being lysed and exam-
ined for changes in tyrosine phosphorylation of total cellular pro-
teins by phosphotyrosine immunoblotting as described in Materi-
als and Methods. Cell migration was determined in modified
Boyden chambers (Transwells) coated with either collagen or vit-
ronectin as described in Materials and Methods. Cell migration
on collagen (1) was greater than 50% of the cell population in 24 h,
while on vitronectin less than 1.0% of the cells migrated. 
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obtained (FG-M cells) that showed spontaneous motility
on vitronectin that was comparable to FG cell migration
on collagen (Fig. 2 
 
A
 
). While FG-M cells gained the ability
to migrate on vitronectin, there was no difference in their
integrin profile or their capacity to adhere to vitronectin
(Fig. 2 
 
A
 
) or a number of other extracellular matrix pro-
teins (data not shown). Therefore, FG-M cells represent a
stable migratory subpopulation of the parental FG cells. 
Cell migration on vitronectin in vitro has been linked to
the metastatic capacity of tumor cells in vivo (Nip et al.,
1992; Brooks et al., 1997). Therefore, we compared FG
and FG-M cells for their ability to metastasize spontane-
ously from the chick chorioallantoic membrane to the
lungs of 10-d-old chick embryos. As shown in Fig. 2 
 
B
 
(
 
bottom
 
), FG-M cells showed a fourfold increase in spon-
taneous metastasis compared with FG cells. However,
there was only a slight increase in the average FG-M pri-
mary tumor weight (1.4-fold) compared with primary tu-
mors formed by FG cells (Fig. 2 
 
B
 
, 
 
top
 
). Furthermore, FG
and FG-M cells had identical growth rates in vitro (data
not shown). These findings suggest that the enhanced mi-
gratory properties of FG-M cells in vitro are primarily as-
sociated with their increased metastatic properties in vivo.
 
FG-M Cells Show Increased CAS
Tyrosine Phosphorylation
 
To establish a possible role of the p125–130 protein(s) in
the migratory capacity of FG-M cells, we compared the
phosphoprotein profile of FG and FG-M cells during their
attachment to vitronectin. As shown in Fig. 3 
 
A
 
, FG-M,
but not FG cell attachment to vitronectin, resulted in the
tyrosine phosphorylation of proteins with a molecular
mass of 125–130 kD. This phosphorylation pattern ap-
peared similar to what was observed between FG cells at-
tached to collagen vs. vitronectin and thus appeared to be
associated with FG cell migration in general (Fig. 1). To-
gether, these data demonstrate that cells selected for spon-
taneous migration in vitro show enhanced invasive proper-
ties in vivo as well as adhesion-dependent phosphorylation
of proteins with a molecular mass of 125–130 kD.
Previous studies have demonstrated that p125 FAK and
p130CAS are phosphorylated upon cell adhesion to matrix
proteins (Ilic et al., 1995; Nojima et al., 1995; Vuori and
Ruoslahti, 1995; Hanks and Polte, 1997). Recently, FAK
has been linked to cell migration since cells lacking this
protein show reduced cell migration in vitro (Ilic et al.,
1995). Therefore, we investigated the possibility that FAK
was a component of the p125–130-kD proteins phosphory-
lated in the FG-M cells. FAK was immunoprecipitated
from vitronectin-attached FG or FG-M cells. The immu-
noprecipitated proteins were then analyzed for the pres-
ence of phosphotyrosine by immunoblotting. Interest-
ingly, both FG and FG-M cells showed a similar increase
in FAK tyrosine phosphorylation upon adhesion to vit-
ronectin (Fig. 3 
 
B
 
). Importantly, FAK phosphorylation
was not readily detectable in total cell lysates prepared
from these cells since they express low levels of this pro-
tein (data not shown). While tyrosine phosphorylation of
FAK appeared identical in these cells, CAS, immunopre-
cipitated from FG-M cells attached to vitronectin, was
highly tyrosine-phosphorylated compared with CAS pre-
cipitated from FG cells (Fig. 3 
 
C
 
). However, CAS immu-
noprecipitated from FG cells attached to collagen was
highly tyrosine phosphorylated, indicating that these cells
have the capacity to phosphorylate this protein (data not
shown). In either case, the enhanced phosphorylation was
not the result of an increase in CAS expression since simi-
Figure 2. Comparison of FG and FG-M cell
migration in vitro and metastasis in vivo.
(A) FG-M cells are a stable cell line derived
from FG cells selected for their ability to
migrate on a vitronectin substrate as de-
scribed in Materials and Methods. Cells
were allowed to adhere for 30 min to Petri
dishes or migrate for 4 h on Transwell mi-
gration chambers coated with vitronectin
(top) or collagen (bottom) and quantified as
described in Materials and Methods. Each
bar represents the mean 6 SD of triplicate
migration wells of one of three representa-
tive experiments. (B) FG or FG-M carci-
noma cells (5 3 106) inoculated onto
chorioallantoic membrane of 9-d-old chick
embryos were allowed to form tumors for
9–10 d, at which time the tumors were re-
sected and weighed (top). Pulmonary me-
tastasis (bottom) was measured as de-
scribed in Materials and Methods. Tumor
weight is the mean 6 SEM. Percent positive
metastasis is the mean 6 SEM of the rela-
tive percentage of tumor cells in the lungs
of the chick embryos. FG-M cells showed a
statistically significant increase in metasta-
sis over FG cells (P , 0.01) as determined
by Student’s t test. 
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lar amounts of this protein were immunoprecipitated from
both cell types (Fig. 3 
 
C
 
). These findings suggest that phos-
phorylation of CAS may be associated with the migratory
properties of these cells.
 
Expression of CAS in Cells Is Sufficient to Promote 
Cell Migration on the ECM 
 
To establish whether CAS played a direct role in cell mo-
tility, we expressed the wild-type form of this molecule in
COS cells since these cells efficiently express proteins en-
coded by eukaryotic expression vectors and show negligi-
ble migration on several ECM proteins after serum starva-
tion (Klemke et al., 1997). Transient expression of CAS in
these serum-starved cells promoted a fourfold increase in
their migration on vitronectin (Fig. 4 
 
A
 
, 
 
top
 
) as well as on
collagen and fibronectin (data not shown). Associated
with this induction of migration was increased tyrosine
phosphorylation of both the expressed CAS (Fig. 4 
 
A
 
,
 
bottom
 
) and endogenous CAS protein (data not shown).
Importantly, expression of CAS did not alter the ability of
these cells to attach to any of the substrates tested (data
not shown), suggesting that CAS expression and its associ-
ated phosphorylation is sufficient to promote cell migra-
tion.
The substrate domain of CAS contains most of the puta-
tive tyrosine phosphorylation sites in this molecule (tyr-
377 to tyr-414) and accounts for a significant portion of its
tyrosine phosphorylation (Sakai et al., 1994). To examine
the role of the CAS substrate domain in CAS-mediated
migration, cells were transfected with either wild-type
CAS or CAS containing an in-frame deletion of its sub-
strate domain (aa 213–514; CAS-SD). As shown in Fig. 4
 
A
 
 (
 
top
 
), cells expressing CAS-SD failed to migrate and did
not show CAS tyrosine phosphorylation in response to cell
attachment (Fig. 4 
 
A
 
, 
 
middle
 
). In addition, transfection of
FG-M cells with CAS-SD reduced their migration on vit-
ronectin and collagen substrates by 
 
.
 
50%. (Fig. 4 
 
B
 
).
These findings provide further evidence that CAS signal-
ing is involved in cell migration and suggests that CAS ty-
rosine phosphorylation of its substrate domain is required
for CAS-induced migration. 
 
Crk Binding to CAS Is Required for the Induction of 
Cell Migration 
 
Tyrosine phosphorylation of CAS within its substrate do-
main is known to promote coupling to the adaptor protein
Crk (Matsuda et al., 1993; Feller et al., 1994
 
b
 
). In fact, 9 of
the 15 tyrosine phosphorylation sites in the CAS substrate
domain conform to the Crk SH2–binding motif (YD (V/T)P.
To investigate the possibility that CAS binding to Crk was
involved in promoting cell migration, COS cells were trans-
fected with Crk and either wild-type CAS or CAS-SD and
then allowed to migrate on a vitronectin substrate after se-
rum starvation. As shown in Fig. 5 
 
A
 
 (
 
top
 
), expression of
either wild-type CAS or Crk promoted a three- to fourfold
increase in cell migration compared with cells expressing
an empty vector. Interestingly, coexpression of both CAS
and Crk in these cells further enhanced their migratory
properties resulting in a seven- to eightfold increase in cell
migration (Fig. 5 
 
A
 
, 
 
top
 
). However, when Crk was ex-
pressed together with CAS-SD, motility was blocked (Fig.
5 
 
A
 
). Similar results were obtained when cells were al-
lowed to migrate on collagen and fibronectin, and expres-
sion of these cDNAs did not influence the ability of these
cells to attach to any of these matrix proteins (data not
shown). In addition, stable expression of Crk in FG cells
was sufficient to promote a 10-fold increase in cell migra-
tion on vitronectin compared with mock-transfected cells
(data not shown). Together, these results suggest that the
interaction between Crk and CAS is critical for migration
on multiple ECM proteins but not attachment of these
Figure 3. FG-M, but not FG
cells, show increased tyrosine
phosphorylation of p130CAS
upon attachment to vitronec-
tin. (A) Serum-starved FG or
FG-M cells were held in sus-
pension or allowed to attach
to vitronectin-coated Petri
dishes for various times be-
fore being lysed in detergent
and analyzed for changes in
tyrosine phosphorylation of
total cellular proteins as de-
scribed in Materials and
Methods. The bracket indicates p125–130 proteins that show increased tyrosine phosphory-
lation in FG-M but not FG cell protein extracts. (B, top) Phosphotyrosine immunoblot of
FAK immunoprecipitated from FG or FG-M cells either held in suspension (S) or allowed
to attach (A) to vitronectin-coated Petri dishes for 15 min. (B, bottom) Blot was stripped
and reprobed with anti-FAK antibodies to confirm equal amounts of protein were precipi-
tated in this experiment. (C) Phosphotyrosine immunoblot of CAS immunoprecipitated from
FG or FG-M cells held in suspension (S) or allowed to attach (A) to vitronectin-coated Petri
dishes for 15 min. (C, bottom) The blot was reprobed with anti-CAS antibodies to confirm
equal amounts of protein were precipitated in this experiment. The result shown is represen-
tative of at least three independent experiments. The Journal of Cell Biology, Volume 140, 1998 966
cells and that CAS-SD serves as a dominant-negative reg-
ulator of cell migration. 
To establish whether the molecular interaction between
CAS and Crk within these migratory cells depended on
the CAS-SD domain, Crk was immunoprecipitated from
an aliquot of the cells used for the migration experiments
above. This immunoprecipitated material was then ana-
lyzed for the presence of tyrosine-phosphorylated CAS.
As shown in Fig. 5 B, wild-type CAS, but not the CAS-SD,
coprecipitated with Crk. As expected, the wild-type CAS,
but not the CAS-SD, was highly tyrosine phosphorylated
(data not shown). These same results were obtained when
CAS was immunoprecipitated and probed for Crk association
(Fig. 5 C). Endogenous Crk could also be coprecipitated
with wild-type CAS but not the CAS-SD (data not shown). 
To determine whether coupling of endogenous CAS/
Crk proteins was associated with the migratory phenotype,
FG or FG-M cells were either held in suspension or al-
lowed to attach to vitronectin for 15 min and examined for
changes in CAS/Crk binding. As shown in Fig. 5 D, FG-M
cell adhesion to vitronectin resulted in significantly in-
creased CAS/Crk coupling compared with FG cells. These
findings reveal that both endogenous and exogenously ex-
pressed CAS and Crk interact with one another through
tyrosine residues present in the substrate domain of CAS
and that this interaction directly influences the migratory
properties of these cells.
The CRK SH2 Domain Is Required for Binding to CAS 
and Induction of Cell Migration
To further establish the role of Crk/CAS binding in cell
migration, cells were cotransfected with wild-type CAS
and Crk with a point mutation in the SH2 domain (Crk-
SH2) that prevents its binding to CAS (Matsuda et al.,
1993; Tanaka et al., 1993). These cells were then tested for
migration and their ability to assemble a CAS/Crk com-
plex. Expression of this mutant Crk with wild-type CAS
not only failed to induce cell migration but was also unable
to couple to CAS (Fig. 6, A and B), indicating that Crk-SH2
served as dominant-negative in this case. Importantly, while
these cells were deficient in migration, they showed no dif-
ferences in their ability to attach or spread on various ECM
proteins (data not shown). Together, these results support
the notion that Crk binding to CAS is critical for the mi-
gratory properties of these cells and that the substrate do-
main of CAS as well as the SH2 domain of Crk contribute
to this response. 
Cell Migration Requires the NH2-terminal SH3 Domain 
of Crk 
Crk-dependent signaling events likely depend on the abil-
ity of this protein to couple via its two SH3 domains to one
or more downstream effector molecules (Matsuda et al.,
1994; Hasegawa et al., 1996). Therefore, we investigated
the role of these SH3 domains in CAS/Crk migration. We
first investigated the role of the NH2-terminal SH3 domain
in the cell migration response by expressing a Crk con-
struct (Crk-SH3N) with a point mutation in this portion of
the molecule, rendering it incapable of binding to effector
molecules (Matsuda et al., 1994). Cells were transfected
with wild-type CAS and either Crk or Crk-SH3N. While
Crk-SH3N readily bound to wild-type CAS protein in
these cells (Fig. 7, bottom), it did not promote cell migra-
tion, whereas the wild-type form of Crk did (Fig. 7, top). In
contrast, expression of Crk with its COOH-terminal SH3
domain truncated readily bound to wild-type CAS and
promoted migration that was comparable to that of cells
Figure 4. Expression of CAS
in cells is sufficient to induce
cell migration. (A, top) Se-
rum-starved COS cells were
allowed to migrate for 3 h on
vitronectin-coated membranes
after transient transfection
with either the empty expres-
sion vector or the expression
vector containing gst-tagged
wild-type CAS (gstCAS-WT)
or gst-tagged CAS lacking
a substrate domain (i.e., aa
213–514 and tyr-377 to tyr-414; gstCAS-SD). The number of transfected
cells migrating were enumerated by counting cells on the underside of
the membrane that coexpressed a b-galactosidase vector as described in
Materials and Methods. Each bar represents the mean 6 SD of triplicate
migration wells of one of three representative experiments. Identical re-
sults were obtained with cells transfected with wild-type CAS or CAS-
SD without the gst tag (data not shown). (A, middle) Phosphotyrosine
immunoblot of gstCAS-WT and gstCAS-SD immunoprecipitated from
COS cells treated as for the migration assay above and attached to the
culture dish. (A, bottom) The blot was reprobed with anti-gst antibodies
to confirm equal loading of gstCAS-WT and gstCAS-SD. (B) Serum-
starved FG-M cells were allowed to migrate on vitronectin- or collagen-coated Transwell membranes after being transiently transfected
with either the empty expression vector or the vector containing CAS-SD along with the b-galactosidase reporter construct as described
in the Materials and Methods. Migration was enumerated as described in A above. The results shown are representative of at least three inde-
pendent experiments. Klemke et al. Commitment to Migrate by Assembly of a CAS/Crk Complex 967
expressing wild-type CAS and Crk (data not shown).
These findings reveal that the NH2-terminal, but not the
COOH-terminal, SH3 domain of Crk is critical for cell mi-
gration. Therefore, the commitment to migrate not only
involves assembly of a CAS/Crk complex but depends on
the NH2-terminal SH3 domain of Crk, which is known to
bind various effector molecules and promote downstream
signaling events.
Figure 5. CAS and Crk promote cell migration. (A) Serum-starved COS cells were allowed to migrate for 3 h on vitronectin-coated
membranes (top) or lysed on the culture dish and analyzed for expression of CAS (middle) and Crk (bottom) by immunoblotting after
transfection with either the empty expression vector or the expression vector containing wild-type Crk (Crk-WT) and/or gstCAS-WT or
gstCAS-SD. The number of transfected migratory cells that coexpressed b-galactosidase were enumerated by counting cells on the un-
derside of the membrane as described in Materials and Methods. Each bar represents the mean 6 SD of triplicate migration wells of one
of three representative experiments. (B) Crk immunoprecipitated from detergent lysates prepared from COS cells transfected as for the
migration assay above were analyzed by blotting with anti-gst (top) or anti-Crk antibodies (bottom). (C) gstCAS-WT or gstCAS-SD im-
munoprecipitated from detergent lysates prepared from COS cells treated as described in B was analyzed by immunoblotting with anti-
gst (top) or anti-Crk antibodies (bottom). (D) Crk immunoprecipitated from detergent lysates prepared from FG or FG-M cells either
held in suspension (S) or allowed to attach (A) to vitronectin for 15 min were analyzed by immunoblotting with anti-CAS (top) or anti-
Crk antibodies (bottom). The results shown are representative of at least three independent experiments.The Journal of Cell Biology, Volume 140, 1998 968
Insulin Promotes Migration in a
CAS/Crk-dependent Manner
Previous work has established that cytokines or growth
factors such as insulin are physiological activators of the
molecular switch leading to cell migration/invasion. This is
important during development, angiogenesis, and wound
repair. In fact, various tumor cell lines stimulated with in-
sulin or insulin-like growth factor not only show increased
migration in vitro but gain the ability to metastasize in
vivo (Klemke et al., 1994, 1997; Brooks et al., 1997). Se-
rum-starved COS cells can be stimulated to migrate after
treatment with various cytokines. Therefore, experiments
were designed to investigate whether cytokine-stimulated
cell migration was also dependent on CAS and Crk. To in-
vestigate this possibility, serum-starved COS cells express-
ing wild-type CAS or CAS-SD were allowed to migrate in
the presence or absence of insulin. As shown in Fig. 8, ex-
pression of CAS-SD, but not wild-type CAS, in COS cells
blocked insulin-induced cell migration without impacting
the adhesion of these cells. Furthermore, expression of
Crk, lacking a functional SH2 or an NH2-terminal SH3 do-
main, also blocked this response (data not shown). Similar
findings were obtained when cells were stimulated with
IGF-1 and EGF (data not shown). Together, these find-
ings demonstrate that CAS and Crk play a critical role in
cytokine/growth factor–mediated cell migration.
Crk and CAS Localize to Membrane Ruffles in 
Migratory Cells 
Targeting of signaling protein complexes to specific re-
gions of the cell is important for the control of various cel-
lular functions (Bar-Sagi et al., 1993). To investigate the
intracellular localization of Crk and CAS, cells expressing
wild-type Crk or CAS were allowed to migrate on vitronec-
tin-coated coverslips for 2–4 h and then examined by im-
munofluorescent staining and confocal microscopy. As shown
in Fig. 9 A, cells expressing either Crk or CAS had a classi-
cal motile phenotype with a leading lamellae containing
membrane ruffles rich in F-actin. Interestingly, both Crk and
CAS proteins were localized to these membrane ruffles
(Fig. 9 A, arrowhead). Importantly, cells expressing wild-type
CAS together with Crk showed a similar motile phenotype
and colocalization of these proteins in membrane ruffles
(data not shown). In contrast, cells within the field of view
not expressing the Crk or CAS cDNAs contained little or
no membrane ruffling and appeared nonmotile (Fig. 9 A). 
To establish the subcellular localization of endogenous
Crk and CAS, serum-starved cells were treated with or
without insulin and stained for the presence of Crk and
CAS. Nonmigratory serum-starved cells showed promi-
nent Crk staining of focal contacts associated with the end
of actin filaments at the cell–substrate interface (Fig. 9 B).
However, after insulin treatment cells showed prominent
membrane ruffles that contained both Crk and CAS (Fig. 9,
B and C). Within the insulin treated cell population, few
focal contacts or stress fibers were observed, which is char-
acteristic of motile cells (data not shown). Together, these
findings demonstrate that both Crk and CAS localize to
the membrane ruffles of migratory cells. 
Rac but Not Ras Activity Is Required for
Crk/CAS-induced Cell Migration
The small G proteins Ras and Rac have been associated
with cell movement (Ridely et al., 1992; Takaishi et al.,
Figure 6. Crk binding to CAS is required for cell migration. (A) Serum- starved COS cells were allowed to migrate for 3 h on vitronec-
tin-coated membranes (top) or lysed on the culture dish and analyzed for expression of Crk and CAS by immunoblotting (middle and
bottom) after transfection with either empty expression vector or the expression vector containing gstCAS-WT and either Crk-WT or
CRK with a mutated SH2 domain (Crk-SH2). The number of transfected cells migrating were enumerated by counting b-galactosidase–
positive cells on the underside of the membrane. Each bar represents the mean 6 SD of triplicate migration wells of one of three repre-
sentative experiments. (B) Crk immunoprecipitated from detergent lysates prepared from COS cells transfected as described for the
migration experiment in A and analyzed by immunoblotting with anti-gst (top) or anti-Crk antibodies (bottom). The results shown are
representative of at least three independent experiments.Klemke et al. Commitment to Migrate by Assembly of a CAS/Crk Complex 969
1993; Michiels et al., 1995). In fact, membrane ruffling has
been linked to the activation state of each of these small G
proteins (Ridely et al., 1992). Therefore, we investigated
the role of Rac and Ras in the Crk/CAS-induced migra-
tion. In these experiments, COS cells cotransfected with
wild-type Crk and CAS together with either dominant-
negative Rac (Rac2) or dominant-negative Ras (Ras2)
were tested for their ability to migrate on ECM proteins.
Expression of Rac2 but not Ras2 in these cells blocked
Crk/CAS-induced cell migration (Fig. 10) and membrane
ruffling (data not shown). In fact, expression of Ras2 was
greater than that of Rac2 in these cells (Fig. 10), yet it still
failed to suppress the Cas/Crk-mediated cell motility re-
sponse. In addition, expression of a dominant-active form
of Rac in these cells failed to promote migration, suggest-
ing that Rac activity was not sufficient to facilitate this
event (data not shown). Neither Rac nor Ras influenced
the adhesive or spreading capacity of these cells, indicating
expression of these constructs was not toxic (data not
shown). Together these results indicate that Rac activity,
but not Ras activity, is required for Crk/CAS-induced cell
migration on the ECM. 
Discussion 
During wound repair and inflammation, cells gain the abil-
ity to migrate once they are stimulated with growth fac-
tors/cytokines. However, cell migration also depends on
adhesive proteins present within the ECM (Clark et al.,
1996; Palecek et al., 1997). In fact, both growth factor re-
ceptors and integrins promote intracellular signals that are
associated with the migratory phenotype of cells (Ridley
et al., 1992; Chen et al., 1994; Klemke et al., 1994, 1997;
Brooks et al., 1997). However, little is known regarding
how these signals activate the cells’ migration machinery,
thereby converting a stationary cell to a migratory cell.
 While adhesion is necessary for cell motility, it is not
sufficient. For example, FG cell attachment to collagen is
permissive for migration, while attachment to vitronectin
is not. This prompted us to examine whether FG cell at-
tachment to collagen or vitronectin produced distinct sig-
naling events. As we show in this study, the increased
phosphorylation of CAS was associated with FG cell adhe-
sion to collagen but not to vitronectin. In addition, selec-
tion of FG-M cells for their ability to spontaneously mi-
grate on vitronectin resulted in a cell population that showed
increased CAS phosphorylation and CAS/Crk coupling
upon adhesion to vitronectin. It is this CAS/Crk complex that
has been associated with downstream signaling events, yet
little is known how these signals influence the biology of cells.
In this report, we demonstrate that assembly of the
CAS/Crk adaptor protein complex serves as a molecular
switch committing a cell to migrate on the extracellular
matrix. This was investigated using cDNAs encoding al-
leles of wild-type Crk and CAS or cDNAs that had been
mutationally altered in critical effector domains. Several
lines of evidence are presented showing that CAS and Crk
play a central role in cell migration. First, expression of
wild-type CAS or Crk in cells was sufficient to induce cell
movement without affecting cell adhesion on various ma-
Figure 7. The NH2-terminal SH3 domain of Crk is required for
CAS/Crk-induced cell migration. (Top) Serum-starved COS cells
were allowed to migrate for 3 h on vitronectin-coated membranes
after transfection with either empty expression vector or the ex-
pression vector containing gstCAS-WT and either Crk-WT or
CRK with a mutation in the NH2-terminal SH3 domain (c-Crk-
SH3(mut)). The number of transfected cells migrating were enu-
merated by counting b-galactosidase–positive cells on the under-
side of the membrane. Each bar represents the mean 6 SD of
triplicate migration wells of one of three representative experi-
ments. (Bottom) Crk-WT or Crk-SH3N immunoprecipitated
from detergent extracts from COS cells transfected as described
for the migration experiment above and immunoblotted for gst-
CAS or Crk. The results shown are representative of at least
three independent experiments.
Figure 8. Requirement of CAS for cytokine-induced cell migra-
tion. Serum-starved COS cells were allowed to migrate for 3 h on
vitronectin-coated membranes in the presence or absence of insu-
lin after transfection with either empty expression vector or the
vector containing gstCAS-WT or gstCAS-SD as described in Ma-
terials and Methods. The number of transfected cells migrating
were enumerated by counting b-galactosidase–positive cells on
the underside of the membrane. Each bar represents the mean 6
SD of triplicate wells. Similar results were obtained after stimula-
tion with IGF-1 and EGF (not shown). The Journal of Cell Biology, Volume 140, 1998 970
Figure 9. Localization of CAS and Crk to membrane ruffles in migra-
tory cells. (A) Serum-starved COS cells were allowed to attach to vit-
ronectin-coated glass coverslips after transfection with the expression
vector containing either wild-type Crk or CAS and examined by confocal
immunofluorescent imaging as described in Materials and Methods.
Rhodamine-conjugated phalloidin was used to visualize F-actin (red),
whereas FITC-conjugated secondary antibody was used to visualize pri-
mary antibodies directed to Crk or CAS (green). Yellow staining repre-
sents the colocalization of red and green staining in the merged image.
Control cells in which the primary antibody was omitted showed no
immunofluorescent staining (data not shown). Photomicrographs were
taken with a Bio-Rad Labs 1024 laser and Zeiss Axiovert microscope
focused at the cell–substratum interface (6303). The arrowheads indi-
cate colocalization of Crk or CAS with F-actin and represent membrane
ruffling of cells showing motile phenotype. (B) Serum-starved COS cells
attached to vitronectin-coated coverslips in the presence (15 min) or ab-
sence of insulin were analyzed by immunofluorescent confocal imaging
for intracellular localization of endogenous Crk with F-actin as de-
scribed above. Photomicrographs were taken at the cell–substratum in-
terface (6303). The arrowhead indicates colocalization of Crk with
F-actin containing membrane ruffles in cells stimulated to migrate with
insulin. (C) Confocal immunofluorescent imaging of endogenous CAS
in COS cells treated as described in B above. Photomicrographs were
taken at the cell–substratum interface (6303). The arrowheads indicate
colocalization of CAS with F-actin containing membrane ruffles in cells
stimulated to migrate with insulin. Bars, 10 mm. Klemke et al. Commitment to Migrate by Assembly of a CAS/Crk Complex 971
trix proteins. Second, this migration event requires the as-
sembly of a CAS/Crk complex involving the binding of
Crk via its SH2 domain to the substrate domain of CAS.
Third, cell migration induced by known regulators of mo-
tility including insulin, EGF, and IGF-1 required functional
Crk and CAS, which were driven to the membrane ruffles
of migratory cells. Finally, the small G protein Rac, which
is involved in regulating signaling events important for
membrane ruffling and cell migration, is required for mi-
gration induced by Crk/CAS. Surprisingly, a dominant-
negative form of Ras failed to block CAS/Crk-induced
motility (Fig. 10), even though it blocked cytokine-medi-
ated cell migration (data not shown). These data suggest
that Rac and Ras promote somewhat distinct pathways of
cell migration. In fact, evidence from our laboratory dem-
onstrates that the Ras/Map kinase (Erk 1 and 2) promotes
cell motility based on the ability of ERK to phosphorylate
myosin light chain kinase (Klemke et al., 1997). While a
dominant-negative form of myosin light chain kinase blocked
Ras-induced motility (Klemke et al., 1997), it failed to in-
hibit CAS/Crk-induced migration. Furthermore, the MEK
inhibitor PD98059 failed to block CAS/Crk-induced cell
migration (Klemke, R., unpublished data). Therefore, it ap-
pears that CAS/Crk-dependent cell migration may represent
a distinct pathway from that initiated by Ras/MAP kinase.
 CAS phosphorylation has been linked to cell adhesion
and depends on kinases such as c-Src and FAK (Harte et al.,
1996; Vuori et al., 1996; Schlaepfer et al., 1997); however,
its susceptibility to phosphatases plays a key role in its
level of phosphorylation (Garton et al., 1996). Therefore,
exogenous expression of CAS could serve as a competitive
substrate for such phosphatases, thereby increasing the
overall level of phosphorylated CAS in the cell. In fact, we
observed that exogenous expression of wild-type CAS not
only caused increased migration but also led to increased
phosphorylation of endogenous as well as expressed CAS
protein (Fig. 4). Likewise, exogenous expression of Crk is
known to protect CAS from dephosphorylation by phos-
phatases (Birge et al., 1992), providing a second mecha-
nism for enhancing the level of phosphorylated CAS in
these cells (data not shown). Therefore, exogenous ex-
pression of either wild-type CAS or Crk would be ex-
pected to enhance the level of CAS phosphorylation, re-
sulting in the generation of CAS/Crk complexes. 
 This study demonstrates that CAS without a substrate
domain and Crk without a functional SH2 or NH2-termi-
nal SH3 domain serve as dominant-negative proteins spe-
cifically blocking cell migration without affecting attach-
ment or spreading of these cells on vitronectin, collagen,
or fibronectin. CAS-SD may block migration by prevent-
ing CAS/Crk complexes from localizing to the appropriate
subcellular location, such as focal adhesion sites or mem-
brane ruffles. Both wild-type and CAS-SD have been
shown to localize to focal contacts in adherent cells, an
event that required the SH3 domain of CAS (Nakamoto
et al., 1997). Expression of Crk-SH2 in cells may block
CAS-mediated migration by competing with endogenous
Crk for important effector molecules that associate with
the NH2-terminal SH3 domain. That expression of Crk-SH3
(N) in cells also blocks CAS-mediated migration supports
this notion. In fact, several signaling molecules are known
to interact with the NH2-terminal SH3 domain of CRK, in-
cluding Abl kinase (Feller et al., 1994a), DOCK 180 (Hase-
gawa et al., 1996), GTP exchange proteins SOS and C3G
(Matsuda et al., 1994; Feller et al., 1995), and the EGF re-
ceptor substrate protein Eps15 (Schumacher et al., 1995).
Alternatively, this SH3 domain may also be involved in
targeting the CAS/Crk complex to a specific cellular location
(Bar-Sagi et al., 1993). To this end, Crk and CAS were found
to colocalize in membrane ruffles of migratory cells (Fig. 9).
While cell adhesion events are required for cell migration,
not all adherent cells move. In fact, cell migration often
depends on signals generated from both growth factor and
adhesion receptors. Our findings suggest that CAS/Crk cou-
pling provides the adhesion-dependent component of this
signaling cascade and, thereby, serves as a molecular switch
promoting cell migration on the extracellular matrix. How-
ever, in transformed cells, CAS/Crk coupling may be con-
stitutive. In fact, v-Crk, a viral oncogene, has been linked to
cell transformation and the malignant phenotype of tumors
(for review see Matsuda and Kurata, 1996). We provide
evidence that CAS/Crk signaling may also influence tumor
cell metastasis. Specifically, FG-M carcinoma cells selected
for spontaneous migration on vitronectin not only showed
enhanced CAS phosphorylation and CAS/Crk coupling
upon adhesion to vitronectin in vitro but also had an increased
metastatic capacity in vivo compared with parental cells that
showed no adhesion-dependent CAS phosphorylation.
 The data presented here provide a mechanism to link
adhesion-dependent signaling events and the formation of
Figure 10. Requirement of Rac, but not Ras, for CAS/Crk-medi-
ated cell migration. (Top) Serum-starved COS cells were allowed
to migrate for 3 h on vitronectin-coated membranes after trans-
fection with either the empty expression vector or the expression
vector containing gstCAS-WT and Crk-WT along with dominant-
negative Rac (2) or dominant-negative Ras (2) . The number of
transfected cells migrating were enumerated by counting cells on
the underside of the membrane as described above. Each bar rep-
resents the mean 6 SD of triplicate migration wells of one of
three representative experiments. (Bottom) An aliquot of those
cells used for the migration assay above were lysed in detergent
and analyzed for myc-tagged Rac or Ras expression as described
in Materials and Methods.The Journal of Cell Biology, Volume 140, 1998 972
a CAS/Crk complex to the activation of a Rac-dependent
cell migration response. The phosphorylation of CAS and
its coupling to Crk serves as a fundamental component of
this signaling cascade. These events may be critical for
growth factor– or cytokine-induced cell migration associ-
ated with development, wound repair, and inflammation.
However, in transformed cells, CAS/Crk complexes may
form spontaneously, leading to invasion events critical for
the dissemination of tumors. 
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